Loading
SANUWAVE Health, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Opaleye Management Inc., was filed 09 Oct 2025.
SANUWAVE Health, Inc.: what insiders have been doing
Every trade that managers of SANUWAVE Health, Inc. disclose to SEC (Form 4) is tracked on this page. The company sits in the Health Care sector. 2 insiders have disclosed 13 filings since 22 October 2025.
The flow runs one way only: 13 sales worth €5.7M, from 2 insiders, and no purchase. The largest single trade was a sale of €3.3M by Manchester Management Co LLC, published on 10 December 2025.
Compared with its exchange (3,171 companies, median 24 filings), a count of 13 filings is below the norm. Over the whole record (from 2016), the tally stands at 16 purchases and 15 sales. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 44.1 m USD and net income of 11.8 m USD.
Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
77
Thresholds
n/a
Buy Volume
€4M
16 ops. · all time
Sell Volume
€6M
15 ops. · all time
Who traded when
BuySaleOpaleye Management Inc.5 buys7 sales
Manchester Management Co LLC6 sales
Iulian Cioanta1 sale
Peter Stegagno1 sale
Since the insiders bought
- -83.7%Entry US$32.26 · Close 21 Oct 2026 US$5.26
- +82.2%Entry US$17.00 · Close at T+365 US$30.97
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 546 of 26,250 companies
83.9
score / 100
Value86
Quality82
FCF yld4.7%
Earn yld29%
EV/EBITDA3.3x
ROE·
Gross mgn77%
Net mgn27%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$4.81
Analyst consensus
Income statement
RevenueUS$44.1M
Gross profitUS$34M77% margin
EBITDAUS$19.4M44% margin
Net incomeUS$11.8M34.7% margin
Valuation
PER (trailing)20.0x
P/Book14.8x
Beta1.42
Balance sheet & cash
Market capUS$41.3M
Total debtUS$23M
Free Cash FlowUS$1.9M
Debt / Equity743%
Profitability & ownership
ROA5.5%
% insiders1.3%
% institutions37.4%
Last declaration on 30 April 2026
Declarations77 total
43,788 shares@ US$18.46741.89% mcap44.5% of flowCommon Stock, par value $0.001 per shareSEC:0001493152-26-020494:0
2,500 shares@ US$18.46740.11% mcap2.5% of flowCommon Stock, par value $0.001 per shareSEC:0001493152-26-020494:1
23,360 shares@ US$17.24760.94% mcap22.2% of flowCommon Stock, par value $0.001 per shareSEC:0001493152-26-020494:2
1,000 shares@ US$17.24760.040% mcap1.0% of flowCommon Stock, par value $0.001 per shareSEC:0001493152-26-020494:3
11,267 shares@ US$20.46110.54% mcap12.6% of flowCommon Stock, par value $0.001 per shareSEC:0001493152-26-018387:0
5,000 shares@ US$20.46110.24% mcap5.6% of flowCommon Stock, par value $0.001 per shareSEC:0001493152-26-018387:1
202 shares@ US$20.50250.0097% mcap0.2% of flowCommon Stock, par value $0.001 per shareSEC:0001493152-26-018387:2
6,500 shares@ US$21.04440.6% of flowCommon Stock, par value $0.001SEC:0000919574-25-007394:1
13,500 shares@ US$31.27984.0% of flowCommon Stock, par value $0.001SEC:0000919574-25-007394:0
8,785 shares@ US$30.58381.2% of flowCommon Stock, par value $0.001SEC:0000919574-25-007315:1
8,625 shares@ US$30.39181.1% of flowCommon Stock, par value $0.001SEC:0000919574-25-007315:2
2,000 shares@ US$31.60170.3% of flowCommon Stock, par value $0.001SEC:0000919574-25-007315:3
125,400 shares@ US$30.7536.4% of flowCommon Stock, par value $0.001SEC:0000919574-25-007315:0
1,267 shares@ US$30.2772.1% of flowCommon Stock, par value $0.001 per shareSEC:0001493152-25-017673:0
Canonical exit: 4 Jan 2026 (T+90)
8,500 sharesCommon StockSEC:0001437749-25-020194:8
80,698 sharesCommon StockSEC:0001437749-25-020194:2
76,215 sharesCommon StockSEC:0001437749-25-020194:3
5,400 sharesCommon StockSEC:0001437749-25-020194:4
5,100 sharesCommon StockSEC:0001437749-25-020194:5
11,500 sharesCommon StockSEC:0001437749-25-020194:6
9,000 sharesCommon StockSEC:0001437749-25-020194:7
6,900 shares@ US$15.00Common StockSEC:0001437749-25-020194:1
103,114 shares@ US$15.00100.0% of flowCommon StockSEC:0001437749-25-020194:0
1,333 shares@ US$15.0023.9% of flowCommon StockSEC:0001437749-25-019907:1
1,862 shares@ US$27.7161.8% of flowCommon StockSEC:0001437749-25-019907:2
25 of 77 declarations
About SANUWAVE Health, Inc.
SANUWAVE Health, Inc. is a company focused on developing technologies for wound and pain treatment. It concentrates on innovative solutions to enhance tissue healing and cellular regeneration.
